|
|
Volumn 61, Issue 1, 2004, Pages 27-32
|
|
Economic benefits of investigational drug services at an academic institution
|
|
Author keywords
Clinical studies; Dispensing; Drugs, investigational; Economics; Methodology; Protocols
|
|
Indexed keywords
NEW DRUG;
ARTICLE;
CALCULATION;
CANCER;
CARDIOVASCULAR DISEASE;
CLINICAL PROTOCOL;
COST BENEFIT ANALYSIS;
DISEASE MANAGEMENT;
DRUG APPROVAL;
DRUG COST;
DRUG MARKETING;
DRUG RESEARCH;
ECONOMIC ASPECT;
ECONOMIC EVALUATION;
FINANCIAL MANAGEMENT;
INFECTION;
METHODOLOGY;
ORGAN TRANSPLANTATION;
PRIORITY JOURNAL;
PSORIASIS;
RHEUMATOID ARTHRITIS;
THROMBOSIS;
UNITED STATES;
UNIVERSITY HOSPITAL;
WORKLOAD;
COST CONTROL;
ECONOMICS;
ORGANIZATION AND MANAGEMENT;
PHARMACY;
STATISTICS;
ACADEMIC MEDICAL CENTERS;
COST SAVINGS;
COST-BENEFIT ANALYSIS;
DRUG COSTS;
DRUGS, INVESTIGATIONAL;
PHARMACEUTICAL SERVICES;
WASHINGTON;
|
|
EID: 1642446122
PISSN: 10792082
EISSN: None
Source Type: Journal
DOI: 10.1093/ajhp/61.1.27 Document Type: Article |
|
Times cited : (32)
|
|
References (5)
|
